Patents by Inventor Patricia A. Rhymer

Patricia A. Rhymer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating cancer
    Publication number: 20030215456
    Abstract: The present invention relates to methods of treating cancer using a combination of a compound which is a PSA conjugate and a tachykinin receptor antagonist, which methods comprise administering to said mammal, either sequentially in any order or simultaneously, amounts of at least two therapeutic agents selected from a group consisting of a compound which is a PSA conjugate and a tachykinin receptor antagonist. The invention also relates to methods of preparing such compositions.
    Type: Application
    Filed: October 2, 2001
    Publication date: November 20, 2003
    Inventors: Sui-Long Yao, Raymond E. Jones, Deborah DeFeo-Jones, David C. Heimbrook, Patricia Rhymer, Pamela J. Wasserbly
  • Method of treating cancer
    Publication number: 20020173451
    Abstract: The present invention relates to methods of treating cancer using a combination of a PSA conjugate and radiation therapy. The methods of this invention comprise administering to a mammal in need amounts of at least one PSA conjugate, in combination with radiation therapy, either sequentially or concomitantly.
    Type: Application
    Filed: October 2, 2001
    Publication date: November 21, 2002
    Inventors: Sui-Long Yao, Raymond E. Jones, Deborah DeFeo-Jones, David C. Heimbrook, Patricia Rhymer, Pamela J. Wasserbly
  • Combination therapy for reducing the risks associated with cardiovascular disease
    Patent number: 6403571
    Abstract: The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase inhibitor in combination with a platelet aggregation inhibitor which is useful for inhibiting platelet aggregation, for inhibiting the formation of thrombotic occlusions, and for treating, preventing and reducing the risk of occurrence of cardiovascular and cerebrovascular events and related vaso-occlusive disorders.
    Type: Grant
    Filed: January 18, 2001
    Date of Patent: June 11, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Robert J. Gould, Steven A. Nichtberger, Patricia A. Rhymer, Lars Olofsson
  • Combination therapy for reducing the risks associated with cardiovascular disease
    Publication number: 20010036913
    Abstract: The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase inhibitor in combination with a platelet aggregation inhibitor which is useful for inhibiting platelet aggregation, for inhibiting the formation of thrombotic occlusions, and for treating, preventing and reducing the risk of occurrence of cardiovascular and cerebrovascular events and related vaso-occlusive disorders.
    Type: Application
    Filed: January 18, 2001
    Publication date: November 1, 2001
    Inventors: Robert J. Gould, Steven A. Nichtberger, Patricia A. Rhymer, Lars Olofsson
  • Combination therapy for reducing the risks associated with cardiovascular disease
    Patent number: 6251852
    Abstract: The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase inhibitor in combination with a platelet aggregation inhibitor which is useful for inhibiting platelet aggregation, for inhibiting the formation of thrombotic occlusions, and for treating, preventing and reducing the risk of occurrence of cardiovascular and cerebrovascular events and related vaso-occlusive disorders.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: June 26, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Robert J. Gould, Steven A. Nichtberger, Patricia A. Rhymer, Lars Olofsson
  • Combination therapy for reducing the risks associated with cardiovascular disease
    Patent number: 6235706
    Abstract: The present invention involves a combination therapy of administering a cholesterol reducing agent, such as a 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitor and a platelet aggregation inhibitor for treating, preventing or reducing the risk of developing cardiovascular and cerebrovascular events and disorders in a mammal.
    Type: Grant
    Filed: May 27, 1999
    Date of Patent: May 22, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Robert J. Gould, Steven A. Nichtberger, Patricia A. Rhymer, Lars Olofsson